ESCRS - OPHTHALMOLOGICA Vol 235 Issue 1 featuring scleral buckle for preserving visual field

OPHTHALMOLOGICA Vol 235 Issue 1 featuring scleral buckle for preserving visual field

OPHTHALMOLOGICA Vol 235 Issue 1 featuring scleral buckle for preserving visual field
TBC Soosan Jacob
Published: Tuesday, February 9, 2016

VOL: 235 ISSUE: 1

SCLERAL BUCKLE BETTER THAN VITRECTOMY FOR PRESERVING VISUAL FIELD

In eyes with primary rhegmatogenous retinal detachment (RRD), the visual function of areas unaffected by the condition is more impaired after pars plana vitrectomy (PPV) than it is after scleral buckle reattachment surgery, according to the results of a prospective, comparative interventional study. It showed that, in 50 eyes with RRD, the postoperative visual field total deviation values for the preoperatively un-detached areas of the retina were significantly better in 25 eyes treated with scleral buckle than in 25 eyes treated with PPV. The authors postulate that vitrectomy may be the more traumatising technique because of the additional measures it can involve, such as fluid-air exchange or gas injection. C Koutsandrea et al, “Scleral Buckling versus Vitrectomy for Retinal Detachment Repair: Comparison of Visual Fields and Nerve Fiber Layer Thickness”, Ophthalmologica 2016; Volume 235, Issue 1 (DOI: 10.1159/000439443).

RANIBIZUMAB EFFECTIVE IN HIGH-RISK PDR

Intravitreal ranibizumab (IVR), alone or in combination with panretinal photocoagulation (PRP), is effective in the treatment of high-risk proliferative diabetic retinopathy (PDR) without vitreoretinal traction, according to the results of a multicentre randomised trial. The study involved 35 high-risk PDR patients and showed that there was a complete regression of disc neovascularisation in 44.4 per cent of eyes treated with PRP plus IVR, 37.5 per cent of eyes treated with IVR alone, and 30.8 per cent of eyes treated with PRP alone. The complete regression rates for new vessels elsewhere were 100 per cent, 75 per cent and 69.2 per cent, respectively. Furthermore, during the one-year duration of treatment, there was no need for laser rescue treatment in IVR-treated eyes. J Figueira et al, “Ranibizumab for High-Risk Proliferative Diabetic Retinopathy: An Exploratory Randomized Controlled Trial”, Ophthalmologica 2016; Volume 235, Issue 1 (DOI: 10.1159/000442026).

CLOSING IN ON GENES FOR HIGH MYOPIA

A case-control study has identified three loci of genetic variants that render individuals among China’s Han population more susceptible to developing high myopia. The loci, ZC3H11B, RSPO1 and GJD2, were among five loci identified in a previous genome-wide association study as being involved in the development of long axial length. The study’s authors genotyped five single nucleotide polymorphisms in 296 unrelated highly myopic individuals and 300 matched emmetropic controls by the SNaPshot method. They compared distribution of genotypes in the cases and controls in codominant, dominant, and recessive genetic models, using SNPStats online software. Li Y et al, “Association between Ocular Axial Length-Related Genes and High Myopia in a Han Chinese Population”, Ophthalmologica 2016; Volume 235, Issue 1 (DOI: 10.1159/000439446).

Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...